ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
rdf:type |
node1 |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
rdf:type |
owl:Thing |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
rdf:type |
prov:Person |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
rdf:type |
foaf:Person |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
owl:sameAs |
https://semopenalex.org/author/A5049279040 |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
http://www.w3.org/ns/org#memberOf |
ripekg:organization/RIPEO272E151A9AD8F585Faculty of Health Sciences |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
foaf:familyName |
Mills |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
foaf:givenName |
Edward |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
foaf:name |
Edward Mills |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
ripe:concerns |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
ripekg:retraction-notice/60864Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: the TOGETHER randomized platform clinical trial |
ripe:concerns |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
ripekg:work/10.1371%2Fjournal.pone.0046909The Cameroon Mobile Phone SMS (CAMPS) Trial: A Randomized Trial of Text Messaging versus Usual Care for Adherence to Antiretroviral Therapy |
dcterms:creator |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |